MoneyWorks4Me

Sanofi India - Quaterly Results

10 May 2023 Evaluate
A minor change in the total revenue was seen in the March 2023 quarter. The total revenue for the quarter stood at Rs. 7365.00 millions against Rs. 7070.00 millions during year ago period.The Net Profit of the company registered a slight decline of -20.13% to Rs. 1904.00  millions from Rs. 2384.00 millions.Operating profit for the quarter ended March 2023 rose to 2557.00 millions as compared to 2189.00 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202212 202112 % Var
Sales 7365.00 7070.00 4.17 7365.00 7070.00 4.17 27701.00 29566.00 -6.31
Other Income 258.00 244.00 5.74 258.00 244.00 5.74 715.00 744.00 -3.90
PBIDT 2557.00 2189.00 16.81 2557.00 2189.00 16.81 7759.00 8369.00 -7.29
Interest 3.00 4.00 -25.00 3.00 4.00 -25.00 17.00 18.00 -5.56
PBDT 2732.00 3366.00 -18.84 2732.00 3366.00 -18.84 9062.00 13243.00 -31.57
Depreciation 97.00 109.00 -11.01 97.00 109.00 -11.01 419.00 667.00 -37.18
PBT 2635.00 3257.00 -19.10 2635.00 3257.00 -19.10 8643.00 12576.00 -31.27
TAX 731.00 873.00 -16.27 731.00 873.00 -16.27 2437.00 3132.00 -22.19
Deferred Tax -7.00 42.00 -116.67 -7.00 42.00 -116.67 -15.00 -228.00 -93.42
PAT 1904.00 2384.00 -20.13 1904.00 2384.00 -20.13 6206.00 9444.00 -34.29
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 34.72 30.96 12.13 34.72 30.96 12.13 28.01 28.31 -1.05
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..